Related Experiment Videos
Natural killer cell function in HIV-1 infected patients
C Fortis1, S Tasca, B Capiluppi
1Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy. fortis.claudio@hsr.it
Summary
Early HIV infection does not impair natural killer (NK) cell activity. However, infected cells may evade immune surveillance by reducing the lysis of autologous dendritic cells (DCs).
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Dendritic cells (DCs) and natural killer (NK) cells interact, requiring cell-cell contact for activation.
- Activated NK cells can eliminate immature DCs, serving as a feedback mechanism to regulate DC-mediated immune responses.
- DCs at mucosal sites can capture HIV and transmit it to CD4+ T cells, initiating infection, while NK cells are crucial for antiviral defense.
Purpose of the Study:
- To investigate the functional status of NK cells during the early stages of HIV infection.
- To explore potential mechanisms by which HIV-infected cells evade natural immune surveillance.
- To examine the interaction between NK cells and autologous DCs in the context of early HIV infection.
Main Methods:
- Analysis of NK cell activity in the context of early HIV infection.
- Assessment of the cytotoxic capacity of NK cells towards autologous DCs.
- Investigation of immune evasion strategies employed by HIV-infected cells.
Main Results:
- Preliminary findings indicate that NK cell activity is not functionally compromised during the early phases of HIV infection.
- HIV-infected cells appear to escape natural immune surveillance through mechanisms including reduced lysis of autologous DCs.
- A cross-talk between DCs and NK cells is essential for the activation of both cell types.
Conclusions:
- NK cells remain active in early HIV infection, suggesting their potential role in controlling viral spread.
- Reduced lysis of autologous DCs by NK cells is a potential mechanism for HIV-infected cells to evade immune detection.
- Understanding DC-NK cell interactions is critical for developing effective HIV immunotherapies.